Estimating Atrial Fibrillation Risk With a Handheld ECG
Part of Heart & circulation clinical trials.
This trial uses a simple, handheld ECG device (like a small card) to check your risk for atrial fibrillation, a common irregular heartbeat. You'll record short heart tracings at home, and the study team will review them to find hidden risk factors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 90 years old
- You are a patient at Massachusetts General Hospital (MGH), either in primary care or a heart (cardiology) clinic
- You have had a standard 12-lead ECG (heart tracing) in the past 5 years
- You have a smartphone or tablet to use with a small, handheld heart monitor
- You have never been diagnosed with atrial fibrillation or atrial flutter
- You do not have a pacemaker, defibrillator, or other implanted heart device
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether sending heart rhythm recordings from a phone (using the KardiaMobile ECG device) can improve health care use and patient experience for people with atrial fibrillation. It may help your care team monitor you more smoothly—if you meet the study requirements.
This study tests whether a smartphone camera can detect an irregular heartbeat (atrial fibrillation) by measuring blood flow through your fingertip. If it works, it could make checking your heart rhythm easier at home.
This trial uses a special long-term heart monitor (one wire) that uses artificial intelligence to find new cases of atrial fibrillation, a type of irregular heartbeat that can increase stroke risk. If you're 60 or older and haven't had AF before, this study could help catch it early.
This trial tests if smartphones and their accessories can detect a specific type of irregular heart rhythm called atrial fibrillation. If you have a form of atrial fibrillation or a normal heart rhythm, you may help see how well these devices work.
This trial tests whether a smartphone app can detect when your heart rhythm normalizes after a procedure called electrical cardioversion. It aims to make monitoring easier and more convenient for patients.
This trial uses a smartphone and smartwatch to track your atrial fibrillation over time. It aims to understand how the condition progresses and the risk of blood clots.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.